Upfront <i>DPYD</i> Genotyping and Toxicity Associated with Fluoropyrimidine-Based Concurrent Chemoradiotherapy for Oropharyngeal Carcinomas: A Work in Progress

<i>Background</i>: 5-FU-based chemoradiotherapy (CRT) could be associated with severe treatment-related toxicities in patients harboring at-risk <i>DPYD</i> polymorphisms. <i>Methods</i>: The studied population included consecutive patients with locoregionally advanced oropharyngeal carcinoma treate...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Antoine Desilets, William McCarvill, Francine Aubin, Houda Bahig, Olivier Ballivy, Danielle Charpentier, Édith Filion, Rahima Jamal, Louise Lambert, Phuc Felix Nguyen-Tan, Charles Vadnais, Xiaoduan Weng, Denis Soulières
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2022-01-01
Rangatū:	Current Oncology
Ngā marau:	<i>DPYD</i> fluoropyrimidine oropharyngeal cancer chemoradiotherapy head and neck cancer pharmacovigilance
Urunga tuihono:	https://www.mdpi.com/1718-7729/29/2/45
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!